Axsome's depression drug enters competitive market after US approval
August 19, 2022 at 11:58 AM EDT
the Food and Drug Administration approved Axsome Therapeutics anti-depression drug Auvelity which reduces symptions as early as one week.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|